Clinical Trials Directory

Trials / Completed

CompletedNCT00628225

Smoking Cessation in Patients With COPD (SMOCC) in General Practice

Status
Completed
Phase
Phase 4
Study type
Interventional
Enrollment
667 (actual)
Sponsor
ZonMw: The Netherlands Organisation for Health Research and Development · Academic / Other
Sex
All
Age
35 Years
Healthy volunteers
Not accepted

Summary

Background: Smoking cessation is the key element in the treatment of patients with Chronic Obstructive Pulmonary Disease (COPD). The role of the general practice in assisting these patients with successful quitting smoking was suboptimal. Therefore we evaluated the effectiveness of two smoking cessation programs (counseling and nicotine replacement) for smokers with COPD in routine general practice, one with (CNB) and one without (CN) the combination with bupropion-SR, compared to usual care (UC) and explored the role of COPD symptoms in successful smoking cessation. Method: RCT with 667 patients with COPD, 68 general practices were randomly allocated. The usual care group (UC) consisted of 148 patients (22 practices), the first intervention group (counseling plus nicotine replacement (CN) of 243 patients (21 practices) and the second intervention group of 276 patients (25 practices. Main outcome measure was (biochemically verified) point prevalence.

Conditions

Interventions

TypeNameDescription
BEHAVIORALCounseling and Nicotine replacement (CN)Professionals in general practice received a central training (4 hours) about smoking, smoking cessation and COPD. They received materials (leaflet, video, smoking cessation protocol and informationfolder). Moreover, professionals received a maximum of 4 practice visits from an outreach visitor. General practitioners were encouraged to advise nicotine replacement. Smoking COPD patients received smoking cessation counseling and were advised to use nicotine replacement.
BEHAVIORALCounseling, Nicotine replacement and Bupropion (CNB)Professionals in general practice received a central training (4 hours) about smoking, smoking cessation and COPD. They received materials (leaflet, video, smoking cessation protocol and informationfolder). Moreover, professionals received a maximum of 4 practice visits from an outreach visitor. The general practitioner was encouraged to advice the patients to use both nicotine replacements and Bupropion-SR. Smoking COPD patients received smoking cessation counseling and were advised to use nicotine replacement and Bupropion-SR.

Timeline

Start date
2000-03-01
Primary completion
2002-12-01
Completion
2003-12-01
First posted
2008-03-04
Last updated
2008-10-17

Locations

1 site across 1 country: Netherlands

Source: ClinicalTrials.gov record NCT00628225. Inclusion in this directory is not an endorsement.